Dmitry Balyasny’s Applied Therapeutics APLT Stock Holding History

Dmitry Balyasny’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,605	Closed	-$35.5K	–	2593
2023 Q4	$35.5K	Buy	+10,605	New	+$26.4K	﹤0.01%	2414

Other funds holding APLT

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Dmitry Balyasny's APLT Position: Q1 2024 in Review

Dmitry Balyasny sold out of Applied Therapeutics (APLT) in Q1 2024, closing a stake of 10,605 shares — an estimated $35.5K sold.

Dmitry Balyasny first reported a position in APLT in Q4 2023 and held it in 1 quarter. The position peaked at $35.5K in Q4 2023. 89 funds tracked by Wall St. Rank hold APLT as of Q1 2024.

Dmitry Balyasny reported no remaining Applied Therapeutics position as of Q1 2024 after selling out during the quarter.
Dmitry Balyasny sold 10,605 Applied Therapeutics shares in Q1 2024, an estimated $35.5K.
Dmitry Balyasny first reported a position in Applied Therapeutics in Q4 2023 and held it in 1 quarter.
Dmitry Balyasny's Applied Therapeutics position peaked at $35.5K in Q4 2023.
89 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.